These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 8348163

  • 1. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO, de Moura MD, Ferriani RA, Bailão LA, de Sá MF.
    Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T, Seehaus D, Korell M, Hepp H.
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 5. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep 01; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 6. [Results of multiple follicular growth with CC + pure FSH + HCG and intrauterine insemination with washed semen].
    Nardo F, D'Agosta S, Bonanno AM.
    Minerva Ginecol; 1994 May 01; 46(5):235-41. PubMed ID: 7936372
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of recombinant equine follicle stimulating hormone (reFSH) to promote follicular growth in mares using a follicular suppression model.
    Jennings MW, Boime I, Daphna-Iken D, Jablonka-Shariff A, Conley AJ, Colgin M, Bidstrup LA, Meyers-Brown GA, Famula TR, Roser JF.
    Anim Reprod Sci; 2009 Dec 01; 116(3-4):291-307. PubMed ID: 19237253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
    Seibel MM, Kamrava MM, McArdle C, Taymor ML.
    Int J Fertil; 1984 Dec 01; 29(1):39-43. PubMed ID: 6146583
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polycystic ovarian disease.
    Raj SG, Talbert LM.
    Obstet Gynecol Annu; 1984 Dec 01; 13():261-73. PubMed ID: 6232474
    [Abstract] [Full Text] [Related]

  • 12. Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
    Traub AI, McFaul PB, Sheridan B, Leslie H.
    Clin Reprod Fertil; 1987 Aug 01; 5(4):167-71. PubMed ID: 3130977
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M, Kiani K, Ghasemi A, Rastegar F, Nabavi M.
    Arch Gynecol Obstet; 2011 Dec 01; 284(6):1431-8. PubMed ID: 21210134
    [Abstract] [Full Text] [Related]

  • 16. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI, Lobo RA, Campeau JD, Tsai HM, Holmberg EA, Ono T, Frederick JJ, Platt LD, diZerega GS.
    J Clin Endocrinol Metab; 1985 May 01; 60(5):922-7. PubMed ID: 3920235
    [Abstract] [Full Text] [Related]

  • 17. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME, Alborzi S, Jahromi BN.
    Int J Fertil Womens Med; 2002 May 01; 47(6):272-7. PubMed ID: 12570169
    [Abstract] [Full Text] [Related]

  • 18. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
    Hamori M, Zwirner M, Clédon P, Tinneberg HR.
    Int J Fertil; 1992 May 01; 37(3):171-5. PubMed ID: 1355764
    [Abstract] [Full Text] [Related]

  • 19. Preimplantation embryo development and serum steroid levels in immature rats induced to ovulate or superovulate with pregnant mares' serum gonadotropin injection or follicle-stimulating hormone infusions.
    Leveille MC, Armstrong DT.
    Gamete Res; 1989 May 01; 23(1):127-38. PubMed ID: 2501205
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and endocrinologic aspects of treatment with pure FSH. A report of experiences].
    Graf M, Freundl G.
    Zentralbl Gynakol; 1990 May 01; 112(2):81-90. PubMed ID: 2107649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.